Global Nasal Drug Delivery Systems Market is Witnessing Major Growth as Aptar Pharma Receives the U.S. FDA approval for Bidose nasal spray device indicated for depression therapy

 

Nasal drug delivery systems are becoming increasingly popular around the globe. This popularity is largely due to its ease of use and improved patient comfort. It has also become a cost-effective method for delivering medication to the widest range of patients. In recent years, other methods of administering drugs have been developed such as oral and intravenous techniques. While the success rate with these other methods of delivery is improving, nasal sprays remain the most reliable means of delivering medications to millions of patients living in all walks of life. Nasal droplets or microspheres are used for delivering different doses of insulin. The method works by the introduction of microspheres into the nose. The surface of the droplets is covered with a protective film to prevent accidental dislodging of the droplets.

Growing patient preference for nasal drug delivery is expected to drive growth of the global nasal drug delivery systems market. Nasal drug delivery is widely accepted by patients since it is easy to administer and has better efficacy. Key players involved in the pharmaceutical industry are focused on launching innovative nasal drug delivery systems, in order to gain a competitive edge in the market. For instance, in January 2021, Tonix Pharmaceuticals entered into a licensing deal with Katana Pharmaceuticals for its intranasal potentiated oxytocin that can be used for metabolic disorders namely diabetes. Furthermore, growing adoption of self-administration practices is expected to propel the global nasal drug delivery systems market growth in the near future.

However, complications related to the overuse of nasal sprays and patent expiry of several drugs are expected to restrain growth of the global nasal drug delivery systems market. Besides, growing focus on over-the-counter nasal drugs can present lucrative growth opportunities in the global nasal drug delivery systems market. Among regions, North America is expected to witness significant growth in the global nasal drug delivery systems market. This is owing to growing consumer awareness about nasal products. Asia Pacific is expected to register a robust growth rate, owing to rising disposable income levels and growing consumer awareness.

Key companies operating the global nasal drug delivery systems market are 3M Company, Pfizer Inc., Neurelis, Inc., Novartis AG, Aptargroup, Inc., Merck & Co., Inc., AstraZeneca PLC, Johnson & Johnson Services, Inc., Becton, Dickinson and Company, and GlaxoSmithKline plc.

For instance, in March 2019, Aptar Pharma received the U.S. Food and Drug Administration (FDA) approval for Bidose nasal spray device indicated for depression therapy.